Cargando…
Human FGF-21 Is a Substrate of Fibroblast Activation Protein
FGF-21 is a key regulator of metabolism and potential drug candidate for the treatment of type II diabetes and other metabolic disorders. However, the half-life of active, circulating, human FGF-21 has recently been shown to be limited in mice and monkeys by a proteolytic cleavage between P171 and S...
Autores principales: | Coppage, Andrew L., Heard, Kathryn R., DiMare, Matthew T., Liu, Yuxin, Wu, Wengen, Lai, Jack H., Bachovchin, William W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4786124/ https://www.ncbi.nlm.nih.gov/pubmed/26962859 http://dx.doi.org/10.1371/journal.pone.0151269 |
Ejemplares similares
-
Fibroblast activation protein is dispensable for control of glucose homeostasis and body weight in mice
por: Panaro, Brandon L., et al.
Publicado: (2018) -
A high-throughput, multiplexed assay for superfamily-wide profiling of enzyme activity
por: Bachovchin, Daniel A., et al.
Publicado: (2014) -
Fibroblast Growth Factor 21 (FGF21) in Human Cerebrospinal Fluid: Relationship With Plasma FGF21 and Body Adiposity
por: Tan, Bee K., et al.
Publicado: (2011) -
Circulating FGF21 proteolytic processing mediated by fibroblast activation protein
por: Zhen, Eugene Y., et al.
Publicado: (2016) -
Lower Cerebrospinal Fluid/Plasma Fibroblast Growth Factor 21 (FGF21) Ratios and Placental FGF21 Production in Gestational Diabetes
por: Tan, Bee K., et al.
Publicado: (2013)